Balaskas, Konstantinos http://orcid.org/0000-0002-7690-6277
Drawnel, Faye
Khanani, Arshad M.
Knox, Paul C.
Mavromaras, George
Wang, Yi-Zhong
Funding for this research was provided by:
F. Hoffman La-Roche Ltd. There is no grant number
F. Hoffman La-Roche Ltd. There is no grant number.
Article History
Received: 23 September 2022
Revised: 25 January 2023
Accepted: 28 February 2023
First Online: 27 March 2023
Competing interests
: KB has served as a consultant for Roche and Novartis and has received speaker fees from Allergan, Alimera, Bayer, Heidelberg Engineering, Novartis and Topcon. FD is an employee of, and holds stock in, F. Hoffmann-La Roche Ltd. AMK has served as a consultant for Adverum, Aerpio, Alimera, Allergan, Apellis, Asclepix, Aviceda, Bausch and Lomb, Broadwing Bio, Chengdu Kanghong, Cholgene, 4DMT, Dutch Ophthalmic Research Centre, Gemini, Genentech, Glaukos, Graybug Vision, Gyroscope, Iveric Bio, Janssen, Kato Pharma, Kodiak, Oculis, Opthea, Oxurion, Novartis, Polyphotonix, Recens Medical, Regeneron, Retrotope, Regenxbio, Roche, Surrozen, Thea and Unity Bio; has received research support from Adverum, Apellis, Asclepix, Chengdu Kanghong, 4DMT, Gemini, Genentech, Graybug Vision, Gyroscope, Iveric Bio, Janssen, Kodiak, Neurotech, NGM Bio, Ocular Therapeutix, Oculis, Opthea, Oxurion, Novartis, Recens Medical, Regenxbio, Roche, Unity Bio; and has received speaker fees from Allergan, Genentech and Novartis. PCK had a research agreement with Vital Art & Science Inc. At the time of writing, GM was an employee of Genentech Inc. and acted as the Lead Product Manager for Home Vision Monitor® app. Before joining Genentech Inc., GM was the Chief Marketing Officer (CMO) for myVisionTrack®, later acquired by Roche/Genentech Inc. Y-ZW has served as a consultant for Genentech, Inc. and Roche, and has patents on mobile visual function testing technology. The funder, F. Hoffmann-La Roche Ltd., is the owner of one of the apps identified in this review (Home Vision Monitor, previously myVisionTrack®). To avoid bias, the authors independently determined the scope of the literature search and developed the search criteria. Equal consideration was given to all literature identified in the search. F. Hoffmann-La Roche Ltd. reviewed the manuscript before submission.